These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

149 related items for PubMed ID: 8314629

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. [Rational and irrational approach to the inotropic agent therapy of heart failure].
    Colombo F, Libretti A.
    Clin Ter; 1988 Sep 30; 126(6):421-6. PubMed ID: 2974404
    [No Abstract] [Full Text] [Related]

  • 5. New positive inotropic drugs in the treatment of congestive heart failure.
    Kennedy GT.
    Prog Cardiovasc Nurs; 1987 Sep 30; 2(3):100-4. PubMed ID: 2959954
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. A multicenter, randomized, blind comparison of amrinone with milrinone after elective cardiac surgery.
    Rathmell JP, Prielipp RC, Butterworth JF, Williams E, Villamaria F, Testa L, Viscomi C, Ittleman FP, Baisden CE, Royster RL.
    Anesth Analg; 1998 Apr 30; 86(4):683-90. PubMed ID: 9539583
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. [New inotropic drugs].
    Presbitero P, Chiotti D.
    Cardiologia; 1988 Aug 30; 33(8):747-53. PubMed ID: 2904301
    [No Abstract] [Full Text] [Related]

  • 10. The role of novel inotropic agents in the treatment of heart failure.
    LeJemtel TH, Keren G, Reis D, Sonnenblick EH.
    J Cardiovasc Pharmacol; 1986 Aug 30; 8 Suppl 9():S47-54. PubMed ID: 2433542
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. [New inotropic agents in the treatment of refractory congestive heart failure].
    Hertzeanu H, Pines A.
    Harefuah; 1988 Mar 15; 114(6):290-3. PubMed ID: 3286406
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Inotropic support of the critically ill patient. A review of the agents.
    Kulka PJ, Tryba M.
    Drugs; 1993 May 15; 45(5):654-67. PubMed ID: 7686461
    [Abstract] [Full Text] [Related]

  • 17. New positive inotropic agents in the treatment of congestive heart failure. Mechanisms of action and recent clinical developments. 2.
    Colucci WS, Wright RF, Braunwald E.
    N Engl J Med; 1986 Feb 06; 314(6):349-58. PubMed ID: 2418353
    [No Abstract] [Full Text] [Related]

  • 18. Is inotropic therapy appropriate for patients with chronic congestive heart failure? Or is the digitalis leaf withering?
    Uretsky BF.
    Postgrad Med J; 1986 Jun 06; 62(728):585-92. PubMed ID: 2946034
    [Abstract] [Full Text] [Related]

  • 19. New positive inotropic agents for congestive heart failure.
    N Engl J Med; 1986 Aug 07; 315(6):396-7. PubMed ID: 3736614
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 8.